similar names can mean different forms
CJC-1295 with an added attachment stays in blood far longer
The compound comes in forms that leave the blood at very different rates. This page explains the extra attachment, the names you may see, and why the distinction matters.
The extra attachment changes how long the compound stays
CJC-1295 with DAC carries an attachment for joining a protein already in blood. CJC-1295 without DAC lacks that attachment, so the compound leaves blood much sooner.
The letters DAC name that extra attachment, rather than a separate treatment. Both forms share four changes made to slow the compound's breakdown [7].
With the attachment, the compound travels alongside blood protein, remaining there for days [7]. Without the attachment, the altered protein leaves blood within minutes to hours.
An estimated 5.8-to-8.1-day fall by half applies only to the attached form. You may see a seller use one name without explaining that difference.
Sellers don't always specify which CJC-1295 form they mean when making a claim. The study behind a claim needs to concern that same form.
The form without an attachment leaves blood in minutes or hours
The short-lasting form has another name you may see
The shorter-lasting form shares four protective changes to resist breakdown [7]. Its other name, Modified GRF, refers to the changed version of a natural growth hormone-releasing hormone.
Sellers may use CJC-1295 for this form, despite its much shorter stay. Both forms prompt the growth hormone gland, but you can't treat their timing as the same.
The form with no attachment leaves blood within minutes to hours [7]. The nineteen eighty-six study found the original natural hormone also left men's blood quickly [6].
Claims about lasting for days concern the form with the extra attachment. Those claims don't describe the short-lasting form you may be reading about.
CJC-1295 DAC stayed longer in the early rat and adult studies
CJC-1295 DAC joins a protein already travelling in blood
CJC-1295 DAC names the form with the extra blood protein attachment. That attachment joins the compound firmly to a protein already moving through blood [7].
Two thousand five: Jette's team compared attached and unattached versions in rats [7]. The attached version raised total growth hormone 4-fold over two hours, or four times the comparison amount.
That comparison was with the unattached version, rather than a test of human treatment. The compound could still be found in rat blood beyond 72 hours.
In the two thousand six study, half the compound left adult blood within an estimated 5.8 to 8.1 days [1]. Repeated shots kept the liver's growth-related hormone raised up to 28 days.
The attachment explains why CJC-1295 stayed longer in those studies. You can't assume that remaining longer makes a treatment better or safer.
The CJC-1295 attached form took 5.8-8.1 days to fall by half
The CJC-1295 5.8-8.1 day estimate describes a blood fall
During two thousand six, Teichman's study followed adults given the longer-lasting CJC-1295 form. Half left blood within an estimated 5.8 to 8.1 days [1].
After repeated shots, the liver's growth-related hormone stayed high up to 28 days. The raised hormone helps cells grow, but a blood rise doesn't prove improved health.
The form with no attachment leaves blood within minutes to hours [7]. The longer-lasting form remains roughly a thousand times longer.
You can't judge a claim about lasting effects when the form isn't named. These studies measured blood changes, rather than a safe plan for treatment.
The attachment keeps CJC-1295 joined to blood protein
CJC-1295 with DAC joins a protein that already travels through your blood [7]. The version without DAC has no such attachment and leaves blood sooner.
Both versions share four changes to the protein that slow breakdown. Those changes alone don't account for the attached version's much longer stay.
CJC-1295 DAC timing does not establish a treatment plan
CJC-1295 DAC names the version with the blood protein attachment [7]. Half left adult blood within an estimated 5.8 to 8.1 days [1].
That timing describes a fall in blood level, rather than how much better anyone felt. The result doesn't settle lasting benefits or safe timing for your shots.